FIGURE 1.
Kaplan–Meier curve of time of persistent use of initial TNFα inhibitor; time until switch to another biological; time until discontinuation TNFα inhibitor without switching for all indications (A), RD (B), IBD (C) and psoriasis (D)
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.